openPR Logo
Press release

Global Genome Engineering Market, by Technology : Clustered regularly interspaced short palindromic repeats (CRISPR), Transcription activator-like effector nuclease (TALEN) & Zinc Finger Nuclease (ZFN) 2017

07-12-2017 12:03 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Genome Engineering

Global Genome Engineering Market, by Technology : Clustered

Albany, New York, July 12, 2017 : Recent research and the current scenario as well as future market potential of "Genome Engineering Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2015 - 2023" globally.

Genome engineering is the synthetic modification of chromosomal DNA by using molecular scissors. Current advances in genome engineering are based on the programmable nucleases that can modify eukaryotic genomes. The global genome engineering market report includes the current and future prospects of the market with an elaborate executive summary, including a market snapshot on various segments and sub-segments. This section also provides the overall information and data analysis of the global genome engineering market with respect to the leading market segments based on type of technology, application, end-user and geography.

Get PDF for more Professional and Technical insights @ http://www.researchmoz.us/enquiry.php?type=S&repid=582310

The market overview section of the report includes qualitative analysis of the overall genome engineering market including the factors determining the market dynamics such as drivers, restraints and opportunities, along with Porter’s five forces analysis. In addition, various analyses such as market attractiveness analysis by geography and competitive landscape by key players has also been provided. The market attractiveness analysis explains the intensity of competition in the market in different geographies. The competitive scenario between different market players is evaluated through market share analysis. These factors would help the market players to take strategic decisions in order to strengthen their positions and expand their share in the global market.

The global genome engineering market has been segmented on the basis of technology, application, end-user and geography. Based on technology, the genome engineering market has been categorized into two major segments: Clustered regularly-interspaced short palindromic repeats (CRISPR), Transcription activator-like effector nuclease (TALEN), Zinc finger nuclease (ZFN) and other technologies, while the other technologies include antisense technology and recombinant AAV mediated genome engineering. Based on application, market has been segmented into Cell-line Engineering, Animal Genome Engineering, Plant genome engineering and Other Application. Based on end-user, the market is segmented into Pharmaceutical and Biotechnology Companies, Academics and Clinical Research Organizations. Market revenue in terms of USD million for the period between 2013 and 2023 along with the compound annual growth rate (CAGR %) from 2015 to 2023 are provided for all the segments, considering 2014 as the base year.

Geographically, the genome engineering market has been categorized into four regions: North America, Europe, Asia Pacific and Rest of the World (RoW). North America comprises the U.S. and Canada. Europe comprises Germany, the U.K., and Rest of Europe. Asia Pacific comprises China, India, and Rest of Asia Pacific. Rest of World comprises of Latin America, Middle-East & Africa. The recommendations section included in the report would assist existing players to expand their market share and new companies to establish their presence in the genome engineering market. The report also profiles major players in the genome engineering market on the basis of various attributes such as company overview, financial overview, business strategies, product portfolio, and recent developments. Major players profiled in this report include Thermo Fisher Scientific, Inc., Sigma-Aldrich Corporation, Sangamo Biosciences, Inc., Lonza Group Ltd., Horizon Discovery Group Plc, and Integrated DNA Technologies, Inc.

Global Genome Engineering Market, by Technology

Clustered regularly interspaced short palindromic repeats (CRISPR)
Transcription activator-like effector nuclease (TALEN)
Zinc Finger Nuclease (ZFN)
Other Technologies

Make an Enquiry of this report @ http://www.researchmoz.us/enquiry.php?type=E&repid=582310

Global Genome Engineering Market, by Application

Overview
Cell Line Engineering
Animal Genome Engineering
Plant Genome Engineering
Other Application

Global Genome Engineering Market, by End-User

Overview
Pharmaceutical and Biotechnology Companies
Academics
Clinical Research Organizations

ResearchMoz is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.

ResearchMoz
90 State Street,
Albany, NY 12207,
United States

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Genome Engineering Market, by Technology : Clustered regularly interspaced short palindromic repeats (CRISPR), Transcription activator-like effector nuclease (TALEN) & Zinc Finger Nuclease (ZFN) 2017 here

News-ID: 620823 • Views: …

More Releases from Genome Engineering

Research of Genome Engineering in Global Industry : Development and Forecast 201 …
Albany, NY, 19 DEC : Genome engineering is the synthetic modification of chromosomal DNA by using molecular scissors. Current advances in genome engineering are based on the programmable nucleases that can modify eukaryotic genomes. The global genome engineering market report includes the current and future prospects of the market with an elaborate executive summary, including a market snapshot on various segments and sub-segments. This section also provides the overall…
Uptick in Funding for Genome Research to Augur Well for Growth of Global Genome …
Researchmoz added Most up-to-date research on "Genome Engineering Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2015 - 2023" to its huge collection of research reports. Genome engineering is the synthetic modification of chromosomal DNA by using molecular scissors. Current advances in genome engineering are based on the programmable nucleases that can modify eukaryotic genomes. The global genome engineering market report includes the current and future prospects of the…

More Releases for Clustered

Clustered Regularly Interspaced Short Palindromic Repeatscrisprtechnology Market …
USA, New Jersey- According to Market Research Intellect, the global Clustered Regularly Interspaced Short Palindromic Repeatscrisprtechnology market in the Internet, Communication and Technology category is projected to witness significant growth from 2025 to 2032. Market dynamics, technological advancements, and evolving consumer demand are expected to drive expansion during this period. Thanks to its groundbreaking uses in gene editing, biotechnology, and medical research, the CRISpen technology market is fast growing. Adoption is…
Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Gene-Editing …
The clustered regularly interspaced short palindromic repeats (CRISPR) gene-editing market is expected to witness market growth at a rate of 26.88% in the forecast period of 2021 to 2028. Data Bridge Market Research report on clustered regularly interspaced short palindromic repeats (CRISPR) gene-editing market provides analysis and insights regarding the various factors are expected to be prevalent throughout the forecast period while providing their impacts on the market's growth. Full Access…
Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Ma …
The market figures in this Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology market report are derived from secondary sources, checked through primary documents, and share assessment; additionally, they are purchased in the market engineering process using the regression approach to arrive at extremely precise and accurate data segment and sub-segment. The market numbers for each section and sub-segment are supported/validated by direct, indirect, and company share analyses, resulting in…
Clustered Regularly Interspaced Short Palindromic Repeats(CRISPR) Technology Mar …
Global Clustered Regularly Interspaced Short Palindromic Repeats(CRISPR) Technology Market Overview: The global Clustered Regularly Interspaced Short Palindromic Repeats(CRISPR) Technology market is expected to grow at a significant pace, reports GLOBAL INFO RESEARCH.  Its latest research report, titled [Global Clustered Regularly Interspaced Short Palindromic Repeats(CRISPR) Technology Market 2020 by Company, Regions, Type and Application, Forecast to 2025], offers a unique point of view about the global market.  Analysts believe that the changing consumption patterns…
New Study on Breast Cancer - First-in-Class Innovation Clustered Around Growth F …
Researchmoz added Most up-to-date research on "Frontier Pharma: Breast Cancer - First-in-Class Innovation Clustered Around Growth Factor Signalling Processes" to its huge collection of research reports. The breast cancer pipeline is the largest in the pharmaceutical industry, with 1,050 products in active development across all stages. The range of mechanisms of action employed by these compounds is also highly diverse, especially in comparison to the existing market landscape. The degree and…
Detailed examination of Frontier Pharma: Breast Cancer - First-in-Class Innovati …
"The Report Frontier Pharma: Breast Cancer - First-in-Class Innovation Clustered Around Growth Factor Signalling Processes provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz" The breast cancer pipeline is the largest in the pharmaceutical industry, with 1,050 products in active development across all stages. The range of mechanisms of action employed by these compounds is also highly diverse, especially in comparison to the…